Tech Company Financing Transactions

Centessa Pharmaceuticals Funding Round

Centessa Pharmaceuticals closed a $250 million Series A investment round on 2/17/2021. Investors included General Atlantic, Janus Henderson Investors and Vida Ventures.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Cambridge, MA 02114
USA

Phone

(617) 468-5770

Website

www.centessa.com

Email Address

[email protected]

Overview

Centessa Pharmaceuticals Limited is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Saurabh Saha

        

Chief Financial Officer

Marella Thorell

        

Chief Financial Officer

Gregory Weinhoff

        

Chief Medical Officer

Antoine Yver

        

Chief Technical Officer

Thomas Templeman

        

VP - Administration

David Chao

        

VP - General Counsel

Iqbal Hussain

        

VP - Regulatory Affairs

Tia Bush

        

Browse more venture capital transactions:

Prev: 2/17/2021: Phlow venture capital transaction
Next: 2/17/2021: Talkiatry venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary